Serotonin Syndrome Market Players, Size, Share, Analysis and Forecast to 2030 Available in New Report
The serotonin
syndrome market report is an informative and in-depth analysis that offers a
detailed overview of the industry, including recent developments and potential
proportions of the demand for serotonin syndrome in terms of products and
services.
The Serotonin
Syndrome Market is expected to reach USD 692.2
Million by 2030 at 4.8% CAGR during the forecast period 2022-2030.
Serotonin
syndrome is a group of symptoms such as high body temperature, increased
reflexes, anxiety, tremor, sweating, diarrhea, dilated pupils, etc. due to the
use of serotonergic drugs. Severe complications, such as seizures and extensive
muscle breakdown, can lead to death. The case of Libby Zion in 1984 is an
example of death from serotonin syndrome. Serotonin syndrome is usually caused
by a synergistic effect of two or more serotonergic drugs, commonly including
serotonin norepinephrine reuptake inhibitor (SNRI), selective serotonin
reuptake inhibitor (SSRI), monoamine oxidase inhibitor (MAOI), tricyclic
antidepressants (TCAs), amphetamines, etc. Many drugs with a high potential to
induce serotonin syndrome include dextromethorphan, buspirone, L-tryptophan,
St. John's wort, metoclopramide, ondansetron, etc. There is no laboratory test
supporting the diagnosis of serotonin syndrome.
Market Dynamics
Treatment for serotonin syndrome
requires the discontinuation of medications that lead to the disorder. Many
treatments for treating related symptoms can be used in severe cases. For
severe cases with life-threatening gastrointestinal decontamination, using activated
charcoal is performed. Sedatives such as benzodiazepines are used in agitated
patients. High fever is a typical symptom of serotonin syndrome that reaches
exceptionally high temperatures of more than 40 centigrade. Cooling measures
can be required to regulate hyperthermia. Serotonin antagonist, such as
cyproheptadine, may be necessary.
Market restraints on serotonin
syndrome are the low number of cases and the equally small number of fatalities
associated with serotonin syndrome in less than 1 % of cases of serotonin
syndrome caused by disease-causing medications. Mild symptoms occur in
approximately 15% of SSRI overdoses.
Major Key
Players:
global Serotonin Syndrome Market Players are Johnson & Johnson,
AstraZeneca Plc., Eli Lilly and Company, Forest Laboratories Inc., Ciron Drugs
& Pharmaceuticals Pvt. Ltd, GlaxoSmithKline plc., Merck & Co., Inc.,
Pfizer, Inc. and Sanofi S.A, and others.
Segment Analysis
The global market
for serotonin syndrome is segmented on serotonin
syndrome treatment and
end-users.
Based on drug
treatment, the market for serotonin syndrome has been segmented as serotonin
antagonists, supportive care(anti-hyperthermics, Muscle relaxants, the control
of autonomic instability, antihypertensive, and others).
Based on
the end-users, the market has been segmented as hospitals, point of care, and
others.
Regional Analysis
The global serotonin syndrome market is segmented into North America,
Europe, the Asia Pacific, and the Middle East & Africa.
North America is further segmented into the United States and Canada.
The United States accounts for the highest market share due to the increased
use of medicines and higher expenditure on healthcare. The rapid consumer
adoption of emerging technology and devices in the United States is also an
essential factor driving the global market for serotonin syndrome.
Europe is the second-largest market due to high disposable incomes and
increased awareness.
The Asia Pacific region is projected to have the most potential for the
future and is predicted to be led by China and India.
The Middle East & Africa market is dominated by Gulf nations,
especially Saudi Arabia and the UAE. Africa's regions are projected to
experience modest growth due to weak economic,
political conditions, and low healthcare penetration.
About Market Research
Future
At Market Research Future (MRFR), we enable our
customers to unravel the complexity of various industries through our Cooked
Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research
Reports (3R), Continuous-Feed Research (CFR), and Market Research &
Consulting Services.
MRFR team have supreme objective to provide the
optimum quality market research and intelligence services to our clients. Our
market research studies by products, services, technologies, applications, end
users, and market players for global, regional, and country level market
segments, enable our clients to see more, know more, and do more, which help to
answer all their most important questions.
In order to stay updated with technology and work
process of the industry, MRFR often plans & conducts meet with the industry
experts and industrial visits for its research analyst members.
Contact us:
Market Research Future
(part of Wantstats Research and Media Private Limited),
99 Hudson Street, 5Th Floor,
New York, New York 10013
United States of America
+1 646 845 9312
Comments
Post a Comment